Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
allogeneic bone marrow (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
fludarabine (fludara) (1 trial)
methylprednisolone (medrol) (1 trial)
sargramostim (leukine) (1 trial)
tacrolimus (prograf) (1 trial)
chm-1101 (1 trial)
Graft vs Host Disease (Phase 3)
Leukemia (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Preleukemia (Phase 3)
Syndrome (Phase 3)
Trials (2 total)
Trial APIs (9 total)